Improve Medical Instruments Co., Ltd.
300030.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.14B
Close$
$1.45
78% downside
Current Fair Value
78% downsideOvervalued by 78% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.14 Billion |
|---|---|
| Enterprise Value | $2.11 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.05 |
| Beta | 0.46 |
| Outstanding Shares | 306,589,486 |
Return
| Return on Equity | 4.62% |
|---|---|
| Return on Assets | 3.02% |
| Return on Invested Capital | 6.00% |
Valuation & Multiples
| P/E Ratio | 71.02 |
|---|---|
| PEG | 315.81 |
| Price to Sales | 6.58 |
| Price to Book Ratio | 3.29 |
| Enterprise Value to Revenue | 4.48 |
| Enterprise Value to EBIT | 48.41 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Improve Medical Instruments Co., Ltd.
632 employees
CEO: Hong Yu Yan Improve Medical Instruments Co., Ltd. operates as an international supplier, delivering advanced technologies, medical products, and critical services to clinical laboratories and for patient care, spanning both the Chinese market and gl...